DataMEDS AI, Inc.
DataMEDS AI, Inc. scores highest on Torque (97) and lowest on Price (0). Its PosiPenta is 33.03 out of 100, weaker than most similar companies.
On the Penta Grid this week, DataMEDS AI, Inc. is Grid #714 of 837 in the Healthcare sector in United States, and Grid #3,429 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| DataMEDS AI, Inc. | 33.03 | 0 | 2 | 15 | 97 | 51 |
| Intensity Therapeutics, Inc. | 31.25 | 37 | 37 | 11 | 45 | 26 |
| Kiora Pharmaceuticals, Inc. | 47.63 | 44 | 28 | 79 | 57 | 30 |
| Citius Pharmaceuticals, Inc. | 35.76 | 49 | 35 | 16 | 43 | 36 |
| Phio Pharmaceuticals Corp. | 43.11 | 42 | 51 | 20 | 57 | 46 |
| Ensysce Biosciences, Inc. | 29.78 | 0 | 53 | 29 | 27 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.06 |
| P/B ratio | -0.61 |
EEarnings
| Trailing EPS | ₹-4421.29 |
| Forward EPS | — |
NNitro
| Price | 249.10 |
| 52-week high | 6914.19 |
| 52-week low | 77.95 |
| Fall from 52-week high | 96.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.99 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹112 Cr |
| Insider holding | 44.47% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is DataMEDS AI, Inc.'s PosiPenta score?
DataMEDS AI, Inc.'s PosiPenta is 33.03 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does DataMEDS AI, Inc. stand on the Penta Grid?
On the Penta Grid this week, DataMEDS AI, Inc. is Grid #714 of 837 in the Healthcare sector in United States, and Grid #3,429 of 4,000 in United States.
Which PosiPenta pillar is strongest for DataMEDS AI, Inc.?
Torque (durability), with a score of 97 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for DataMEDS AI, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.